Contributors


Jaclyn Andronico

Latest:

An Oncology Nurse at Heart

This essay was written by her colleagues, Jeanine Gordon and Jaclyn Andronico, Memorial Sloan Kettering Cancer Center, nominating Lisa Klempner, M.S.N., RN, OCN for CURE®’s 2019 Extraordinary Healer® Award.


Alexandra Hurd

Latest:

People & Places

Ed Bradley, Lance Armstrong Foundation, Betty Agassi, Farah Fawcett


Alan Birch

Latest:

Filling the Medication Gap

It can be challenging and confusing to get prescription drugs paid for in Canada. Drug access navigators can help.



Debra Violette

Latest:

A Personal Journey: Improving the Lives of People With Lung Cancer

It's been 17 years since my diagnosis of stage 3a non–small cell lung cancer. I can remember that moment as if it was yesterday.





Mack

Latest:

Finding a New Friend Through Cancer

An Extraordinary Healer essay honoring Debbie O’Sullivan, RN, OCN [UT Health Northeast Cancer Treatment and Prevention Center in Tyler, Texas]


Heather Venrick

Latest:

Web Exclusive: A Granddaughter's Eulogy

Heather Venrick honors her grandmother.


Ursula A. Matulonis, M.D.

Latest:

What to Expect When Going on a PARP Inhibitor for Ovarian Cancer

Chemotherapy and PARP inhibitors may share some side effects, but there are some major differences between the two when it comes to treating ovarian cancer.


Robert Heywood

Latest:

What to Do When a Friend Gets Cancer

A prostate cancer survivor offers his thoughts on what you should (and shouldn't) say to someone who was recently diagnosed.


Debra Goldstein

Latest:

My Healing Journal

Healing journal by Debra Goldstein


Jayne O’Malley, RN, B.S.N., OCN Lung Cancer Patient Navigator

Latest:

Helping Patients Fight Cancer With All Her Heart and Soul

An essay honoring SARA SARGENTE, RN, OCN [ORANGE REGIONAL MEDICAL CENTER, MIDDLETOWN, NEW YORK]



Shannon Pulaski

Latest:

Let's Talk About Cancer Prevention and the Power of Support

"I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive."


Kathy Boltz, PhD

Latest:

Long-Term Data Show Optune Offers a Survival Benefit in Glioblastoma

Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.


Geoffrey Norman

Latest:

Survivors and Healers

I didn’t like thinking of myself as a “survivor.” There was something … I don’t know. Something a little shameful, maybe, about it.


Deborah Morosini, MD

Latest:

A Hole In The World

Dana Reeve's death revealed the other face of lung cancer.


Jo Cavallo

Latest:

Uncertain Obligations

Navigating the emotional and practical hurdles of caring for parents and stepparents.


Linda Nabozny (sister)

Latest:

Good Karma From My Oncology Nurse, a Kindred Spirit

An Extraordinary Healer essay honoring Sharon Bird, BSN, RN [ THOMAS JEFFERSON UNIVERSITY HOSPITAL IN RADNOR, PENNSYLVANIA ]



Michael J. Overman, M.D.

Latest:

MSI Testing Is Crucial in Colorectal Cancer

Genetic testing – particularly for microsatellite instability (MSI) – is an important step for all patients diagnosed with colorectal cancer.



Rita Colorito

Latest:

Discussing PARP Inhibitors in Triple-Negative Breast Cancer

As the treatment paradigm shifts for triple-negative breast cancer, PARP inhibitors will continue to play a role.


Francesca Consagra

Latest:

The Space In Between

One woman reflects on the fact that no one is immortal.



Jeremy Pivor

Latest:

Yellow Tagged at my Infusion - It's Better to be Safe than Sorry

Going in for an infusion amid the coronavirus pandemic with a possible "symptom" of COVID-19 and wondering what risks lie ahead.


Cannon McMullin

Latest:

Eleven-Year-Old MPN Hero Remains Positive in the Face of Uncertainty

Cannon McMullin was diagnosed with essential thrombocythemia at 8 years old and has remained positive through years of treatment by focusing on the things he likes to do.


Kay Verble

Latest:

Kay Verble Discusses a Study to Characterize Long-Term Survivors of GBM

Kay Verble discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).